Adam Logal
Director of Finance/CFO chez OPKO HEALTH, INC.
Fortune : 214 997 $ au 31/03/2024
Profil
Mr. Adam E.
Logal is a Chairman at Xenetic Biosciences, Inc. and a CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. He is on the Board of Directors at Bio-Reference Laboratories, Inc. and OPKO Biologics Ltd.
Mr. Logal was previously employed as an Independent Director by VBI Vaccines, Inc., a Finance Director, Secretary, Treasurer & CAO by eXegenics, Inc., and a Chief Financial & Accounting Officer by Nabi Biopharmaceuticals.
He also served on the board at SciVac Therapeutics, Inc.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
OPKO HEALTH, INC.
0,03% | 29/02/2024 | 179 164 ( 0,03% ) | 214 997 $ | 31/03/2024 |
06/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Adam Logal
Sociétés | Poste | Début |
---|---|---|
OPKO HEALTH, INC. | Director of Finance/CFO | 31/03/2014 |
BIO-REFERENCE LABORATORIES INC | Director/Board Member | 20/08/2015 |
XENETIC BIOSCIENCES, INC. | Chairman | 14/08/2017 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Director/Board Member | 01/04/2014 |
Anciens postes connus de Adam Logal
Sociétés | Poste | Fin |
---|---|---|
VBI VACCINES INC. | Director/Board Member | 01/10/2018 |
eXegenics, Inc. | Director of Finance/CFO | 13/06/2007 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Director of Finance/CFO | 01/01/2007 |
SciVac Therapeutics, Inc. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
OPKO HEALTH, INC. | Health Services |
XENETIC BIOSCIENCES, INC. | Health Technology |
VBI VACCINES INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
eXegenics, Inc. | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
SciVac Therapeutics, Inc. | Health Technology |